{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:48:03Z","timestamp":1792507683093,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.neuropharm.2006.08.011","type":"journal-article","created":{"date-parts":[[2006,9,30]],"date-time":"2006-09-30T07:24:00Z","timestamp":1159601040000},"page":"415-422","source":"Crossref","is-referenced-by-count":203,"title":["Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats"],"prefix":"10.1016","volume":"52","author":[{"given":"Stefania","family":"Petrosino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enza","family":"Palazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"de Novellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Bisogno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabatino","family":"Maione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Di Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2006.08.011_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1517\/14656566.7.5.607","article-title":"Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain","volume":"7","author":"Barnes","year":"2006","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-2999(00)00226-0","article-title":"Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat","volume":"396","author":"Beaulieu","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in the rat that produces disorders of pain sensation like those seen in the man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2006.08.011_bib4","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1096\/fj.05-4743fje","article-title":"Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice","volume":"20","author":"Bilsland","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib5","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1074\/jbc.272.6.3315","article-title":"Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes","volume":"272","author":"Bisogno","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib6","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/sj.bjp.0705587","article-title":"Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain","volume":"141","author":"Costa","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib8","unstructured":"Costa, B., Colleoni, M., Trovato, A.E., Conti, S., Pomelli, F., Franke, C., 2005. Anandamide uptake and hydrolysis as targets for the treatment of neuropathic pain: effect of AM404 and URB597 in rats with chronic constriction injury of the sciatic nerve. XV Symposium on the Cannabinoids, Clearwater Beach, FL, 24\u201329 June 2005, p. 33."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib9","unstructured":"Costa, B., Comelli, F., Colleoni, M., Giagnoni, G., 2006. Effect of CB1\/TRPV1 agonist, arvanil, in acute inflammation and in persistent inflammatory and neuropathic pain. XVI Symposium on the Cannabinoids, Tihany, Hungary, 24\u201329 June 2006, p. 38."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/neu.20080","article-title":"The endogenous cannabinoid system and its role in nociceptive behavior","volume":"61","author":"Cravatt","year":"2004","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib11","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.neuropharm.2005.01.001","article-title":"Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies","volume":"48","author":"Darmani","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2006.08.011_bib12","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.bcp.2005.05.011","article-title":"Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels","volume":"70","author":"de Lago","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0014-5793(01)02934-9","article-title":"Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors","volume":"506","author":"De Petrocellis","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1124\/jpet.103.062836","article-title":"3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59\u20133074): a novel cannabinoid Cb1\/Cb2 receptor partial agonist with antihyperalgesic and antiallodynic effects","volume":"310","author":"De Vry","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib15","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2006.08.011_bib16","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0959-4388(02)00340-9","article-title":"Endovanilloid signaling in pain","volume":"12","author":"Di Marzo","year":"2002","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neulet.2004.06.060","article-title":"Cannabinoids block tactile allodynia in diabetic mice without attenuation of its antinociceptive effect","volume":"368","author":"Dogrul","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2174\/1389557033487818","article-title":"Cannabinoids and neuropathic pain","volume":"3","author":"Goya","year":"2003","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib19","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1523\/JNEUROSCI.3258-04.2005","article-title":"The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling","volume":"25","author":"Haj-Dahmane","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib20","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/S0024-3205(03)00651-9","article-title":"Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat","volume":"73","author":"Helyes","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(96)13308-5","article-title":"The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agoinst, in a rat model of neuropathic pain","volume":"221","author":"Herzberg","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib22","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/nature03658","article-title":"An endocannabinoid mechanism for stress-induced analgesia","volume":"435","author":"Hohmann","year":"2005","journal-title":"Nat. Lett."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.bjp.0706510","article-title":"Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models","volume":"147","author":"Jayamanne","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib24","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.neuropharm.2005.05.003","article-title":"Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats","volume":"49","author":"Kanai","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2006.08.011_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2004.06.011","article-title":"Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors","volume":"496","author":"Kelley","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2005.10.046","article-title":"Dorsal raphe nucleus and locus coeruleus neural networks and the elaboration of the sweet-substance-induced antinociception","volume":"395","author":"Kishi","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib27","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1124\/jpet.105.100792","article-title":"Modulation of neuropathic and inflammatory pain by the endocannabinoid Transport inhibitor AM404","volume":"317","author":"La Rana","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1124\/jpet.104.069401","article-title":"Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity","volume":"311","author":"Lichtman","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.pain.2004.01.022","article-title":"Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia","volume":"109","author":"Lichtman","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2006.08.011_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0304-3959(03)00242-2","article-title":"Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats","volume":"105","author":"Lim","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2006.08.011_bib31","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1124\/mol.105.015644","article-title":"Phosphorylation-dependent desensitization by anandamide of vanilloid receptor-1 (TRPV1) function in rat skeletal muscle arterioles and in Chinese hamster ovary cells expressing TRPV1","volume":"69","author":"Lizanecz","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib32","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1124\/jpet.105.093286","article-title":"Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptors type I and transient receptor potential vanilloid type 1 receptors","volume":"316","author":"Maione","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib33","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","article-title":"The endogenous cannabinoid system controls extinction of aversive memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2006.08.011_bib34","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1073\/pnas.060496197","article-title":"Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human","volume":"97","author":"Mezey","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib35","unstructured":"Mitrirattanakul, S., Ramakul, N., Guerrero, A.V., Matsuka, Y., Ono, T., Iwase, H., Mackie, K., Faull, K.F., Spigelman, I., Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain. Pain [Epub ahead of print], in press."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1749-6632.2000.tb06673.x","article-title":"Spinal and supraspinal mechanisms of neuropathic pain","volume":"909","author":"Ossipov","year":"2000","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib37","unstructured":"Palazzo, E., de Novellis, V., Petrosino, S., Marabese, I., Vita, D., Giordano, C., Di Marzo, V., Rossi, F., Maione, S., Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system. Eur. J. Neurosci., in press."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pain.2005.07.008","article-title":"A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats","volume":"118","author":"Pascual","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2006.08.011_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3959(02)00368-8","article-title":"Descending modulation in persistent pain: an update","volume":"100","author":"Ren","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2006.08.011_bib40","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000176753.45410.8b","article-title":"Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis","volume":"65","author":"Rog","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2006.08.011_bib41","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1113\/jphysiol.1979.sp012628","article-title":"Serotonergic innervation of the locus coeruleus from the dorsal raphe and its action on responses to noxious stimuli","volume":"286","author":"Segal","year":"1979","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neulet.2004.08.061","article-title":"The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats","volume":"371","author":"Ulugol","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib43","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/jnr.20821","article-title":"Characterization of chronic constriction of the saphenous nerve, a model of neuropahtic pain in mice showing rapid molecular end electrophysiological changes","volume":"83","author":"Walczak","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib44","doi-asserted-by":"crossref","first-page":"12198","DOI":"10.1073\/pnas.96.21.12198","article-title":"Pain modulation by release of the endogenous cannabinoid anandamide","volume":"96","author":"Walker","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2006.08.011_bib45","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1523\/JNEUROSCI.23-08-03221.2003","article-title":"Focal lysolecithin-induced demyelination of peripheral afferents results in neuropathic pain behaviour that is attenuated by cannabinoids","volume":"23","author":"Wallace","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib46","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0169-409X(03)00098-X","article-title":"Animal and cellular models of chronic pain","volume":"55","author":"Wang","year":"2003","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib47","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/j.1471-4159.2004.02544.x","article-title":"Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice","volume":"89","author":"Witting","year":"2004","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2006.08.011_bib48","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1046\/j.1460-9568.2003.02704.x","article-title":"Induction of CB2 receptor expression in the rat spinal cord of neuropatic but not inflammatory chronic pain models","volume":"17","author":"Zhang","year":"2003","journal-title":"Eur. J. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390806002802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390806002802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T07:03:19Z","timestamp":1587193399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390806002802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0028390806002802"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2006.08.011","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}